This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
The drivers behind the demand for ADCs Providing more targeted therapeutic options in the oncology space has underpinned the rapid growth of the ADC market; between 2016 to 2020, the US ADC market grew by 45 percent to a value of nearly $1.5 Petra holds a D.Phil in synthetic organicchemistry and am MBA from Imperial College London.
I started my journey in chemistry – first as an undergraduate and then in my PhD programme at the University of Houston, where I focused on organicchemistry and nucleic acids chemistry. Can you tell us about your journey in the field of STEM and the challenges you encountered along the way?
Despite excellent pharmacokinetic and stable antibody-linker connections, such ADCs have yet to receive market approval. With a passion for organicchemistry, Léo’s expertise lies in the meticulous design and synthesis of compounds crucial to advancing medical science.
Presenters: Dr. Haydn Boehm, Head of Commercial Marketing – Connected Lab at Merck Group. Haydn Boehm is the Head of Commercial Marketing for Merck’s Connected Lab digital program and has over 20 years’ experience in marketing and business development within the life scientific sector.
A graduate of the Hebrew University of Jerusalem, he earned a Bachelor of Science in chemistry and physics and a Master of Science in physical organicchemistry before completing a Doctor of Philosophy in 1971.
He continued his education at Indiana University, where he completed a Master of Arts in botany in 1964, and a Doctor of Philosophy in organicchemistry in 1965. He attributes his success to good fortune and hard work, and hopes to see some of his patented compounds gain approval and reach market readiness in the coming years.
Coupling my desire to be a scientist with my keen sense of adventure, I moved to Alaska out of high school to begin my undergraduate studies in chemistry, applying myself to my STEM classes whilst also climbing mountains and chasing Northern Lights.
He focused on corporate and business unit strategies, organizational transformations, product launches, growth strategies and new market entries. Retterath joins Spark from Bain & Company, where he served as a partner in the healthcare practice for a decade.
Dennis obtained his PhD in OrganicChemistry from the University of Göttingen in 2013 specializing in carbohydrate chemistry and transition-metal catalysis. Interestingly, the molecules with the highest predicted and observed Kp,uu’s had no transporter liability, as indicated by the white circles in the graphs in Figure 10.
Dr Lopa Bakrania brings over 18 years of experience in pharmaceutical process chemistry and CMC regulatory affairs. As Executive Director of CMC Regulatory Affairs at Biohaven , she leads efforts to develop innovative therapies from the clinic to market approval. When I joined, I was one of only five women on a team of 150 men.
We organize all of the trending information in your field so you don't have to. Join 15,000+ users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content